Nifedipine controlled delivery by sandwiched osmotic tablet system

被引:128
作者
Liu, LX
Ku, J
Khang, G
Lee, B
Rhee, JM
Lee, HB
机构
[1] Chonbuk Natl Univ, Dept Polymer Sci & Technol, Chonju 561756, South Korea
[2] Pukyang Natl Univ, Dept Polymer Engn, Pusan 608739, South Korea
[3] Korea Res Inst Chem Technol, Biomat Lab, Taejon 305606, South Korea
关键词
nifedipine; osmotic pump; 24-hour delivery; sandwiched osmotic tablet system;
D O I
10.1016/S0168-3659(00)00243-1
中图分类号
O6 [化学];
学科分类号
0703 [化学];
摘要
The sandwiched osmotic tablet system (SOTS), which is composed of a sandwiched osmotic tablet core surrounded by a cellulose acetate membrane with two orifices: on both side surfaces, has been successfully prepared with the purpose of delivering nifedipine. The sandwiched osmotic tablet core consists of a middle push layer and two attached drug layers. Influences of tablet formulation variables, orifice size and membrane variables on nifedipine release of SOTS have been studied. It was found that potassium chloride amount of push layer and polyethylene oxide amount of drug layer had markedly positive effects on nifedipine release. A push layer/drug layer co-controlled osmotic delivery mechanism and the optimal core formulation have been proposed. The appropriate orifice size was observed in the range of 0.50-1.41 mm. It was also found that the drug release rate of SOTS could be increased by incorporating hydrophilic plasticizer in the membrane, whereas it decreased with hydrophobic plasticizer. It has been observed that the SOTS gives fairly comparable in vitro release features as that of commercialized push-pull osmotic tablet system, such as an approximately constant rate up to 24 h and independence of release media and agitation rate. Exempting side identification before drilling, it is easier to prepare the SOTS than the push-pull osmotic tablet system. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:145 / 156
页数:12
相关论文
共 26 条
[1]
Ali S.L., 1989, ANAL PROFILES DRUG S, P221
[2]
BUDAVARI S, 1989, MERCK INDEX, P9504
[3]
Chen C.-M., 1998, U.S. Patents, Patent No. 5736159
[4]
CHEN CM, 1998, Patent No. 5837379
[5]
CORTESE R, 1984, Patent No. 4449983
[6]
GEERKE JH, 1997, Patent No. 5658474
[7]
Studies on dissolution testing of the nifedipine gastrointestinal therapeutic system .1. Description of a two-phase in vitro dissolution test [J].
Grundy, JS ;
Anderson, KE ;
Rogers, JA ;
Foster, RT .
JOURNAL OF CONTROLLED RELEASE, 1997, 48 (01) :1-8
[8]
The nifedipine gastrointestinal therapeutic system (GITS) - Evaluation of pharmaceutical, pharmacokinetic and pharmacological properties [J].
Grundy, JS ;
Foster, RT .
CLINICAL PHARMACOKINETICS, 1996, 30 (01) :28-51
[9]
NEWLY DISCOVERED PHOTODEGRADATION PRODUCTS OF NIFEDIPINE IN HOSPITAL PRESCRIPTIONS [J].
HAYASE, N ;
ITAGAKI, Y ;
OGAWA, S ;
AKUTSU, S ;
INAGAKI, S ;
ABIKO, Y .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1994, 83 (04) :532-538
[10]
LIU L, 2000, IN PRESS J CONTROL R